Business Daily from THE HINDU group of publications
Saturday, Sep 27, 2008
ePaper | Mobile/PDA Version | Audio | Blogs

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Venture Capital
Industry & Economy - Medical Institutions & Hospitals
Slowdown may bring more private equity players into healthcare

G. Krishnaswamy

Dr C. Pratap Reddy, Chairman, Apollo Hospitals, addressing the ISB healthcare and pharma conclave in Hyderabad on Friday. —

Our Bureau

Hyderabad, Sept. 26 The life sciences and healthcare sector may benefit from the global economic slowdown as global investors, especially private equity players (PEs), are expected to move to this sector from hitherto popular sectors ones like IT and ITeS.

This was the view expressed by Mr Jasmin Patel, Managing Director, Fidelity International in a presentation at healthcare and pharma conclave organised by the Indian School of Business (ISB) here on Friday.

The PE investment in the life sciences and healthcare sector till August this year was $9.4 billion, he said adding, “Some predict a 50 per cent slowdown in PE investment in India by 2010, due to the impact of global economy,” he said. The hospitals in tier II, III cities, super-specialty hospitals and medical equipment businesses provide lot of investment opportunities, he added.

Dr Pratap C. Reddy, Chairman, Apollo Hospitals Group said Rs 80,000 crore investment was required every year to create the necessary hospital bed capacity in the country.

“There is a gap in the demand and supply of human resources which needs to be addressed immediately. For instance, we have only 1.6 million doctors while we need over seven lakh doctors,” he said.

The regulations and curricula set by Medical Council of India should be changed to allow private players into higher medical education, he suggested. Dr Mohan Chellapa, President of Global Ventures, Johns Hopkins Medical International, US said the demand for healthcare services is rapidly growing in China and India. “There has been a shift in the disease pattern from infectious diseases to degenerative diseases in the developing markets,” he said.

More Stories on : Venture Capital | Medical Institutions & Hospitals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page




Stories in this Section
DuPont opens corn research centre to boost output


Deutsche Bank picking up stake in BPL
Balmer Lawrie dividend at 170%
Anjani Portland declares dividend
Why a liberal tax regime for LLPs?
Tata Motors files writ petition
Golden Tobacco announces demerger of realty business
Jain Irrigation plans hub to make micro-irrigation systems
FLSmidth to expand Chennai engg centre
Launch of Jazz to be advanced to mid-2009
Orra to set up two more jewellery facilities
IOC awaits Turkish response to project proposals
Aurobindo drug gets FDA nod
Pokarna, Hugo Boss enter pact
Slowdown may bring more private equity players into healthcare
Lanco Infra may enter power, solar sectors
Ratnagiri hopes to raise power capacity by Oct
Nestle to invest Rs 600 crore in India next year
Ministry asks Serious Fraud Office to probe Elder Pharma case




Life



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line